CONTINUUS Pharmaceuticals

company

About

Continuus Pharmaceuticals designs, builds, and runs manufacturing processes for pharmaceutical and generic clients.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$150K
Industries
Biotechnology,Manufacturing,Medical,Pharmaceutical
Founded date
Nov 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle.

CONTINUUS Pharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.40M
CONTINUUS Pharmaceuticals has raised a total of $1.40M in funding over 2 rounds. Their latest funding was raised on Feb 29, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 29, 2016 Grant $1.25M 1 National Science Foundation Detail
Dec 11, 2014 Grant $150K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
CONTINUUS Pharmaceuticals is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant